Hudson Executive Investment Corp. II (HCII) operates as a blank check company whose primary purpose centers on effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities; it conducts no significant operations and generates no revenue prior to completing such a transaction. The company focuses its search primarily on technology-driven, disruptive companies in high-growth industries including fintech and healthcare, with potential targets exhibiting desirable growth characteristics, high barriers to entry, and sustainable competitive advantages. Incorporated in 2020 and headquartered in New York, New York, HCII raised $200 million in its January 2021 initial public offering underwritten by Citi, J.P. Morgan, and Barclays, with proceeds held in trust at 100% of IPO cash; it was formerly known as Hudson Executive Investment Corp. III before changing its name in December 2020.
In November 2022, the company's board determined to dissolve and liquidate HCII after failing to consummate an initial business combination within the required timeframe under its Amended and Restated Certificate of Incorporation, leading to the redemption of all outstanding public shares at approximately $10.10 per share on December 21, 2022, and subsequent delisting from Nasdaq via Form 25 followed by Form 15 to terminate SEC registration.